Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

NCT04259255 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
ALS

Interventions

DRUG: Edaravone (Radicava®/Radicava ORS®)

Sponsor

Tanabe Pharma America, Inc.

Collaborators

[object Object]